We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
In this special report, Drug Industry Daily examines how the drug supply chain has evolved during the pandemic. Part 1 focuses on the special challenges to manufacturers of generics.Read More
Bristol Myers Squibb (BMS) has filed a complaint in federal court alleging AstraZeneca’s cancer therapy Imjudo (tremelimumab) infringes on its blockbuster immunotherapy drug Yervoy (ipilimumab). Read More
The company will pay for six doses if treatment had been discontinued because the patient still had low platelet counts after four days of combined treatment with Cablivi, plasma exchange and immunosuppressive therapy. Read More
Astellas Pharma has filed a federal lawsuit accusing China’s Qilu Pharma of infringing on its patent protections for the blockbuster overactive bladder drug Myrbetriq (mirabegron) by preparing a generic version. Read More